Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome

OBJECTIVES: The purpose of the present study was to investigate the safety and tolerability of the monoaminergic stabilizer (‐)‐OSU6162 in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In addition, a potential therapeutic effect of (‐)‐OSU6162 in ME/CFS was evaluated by...

Descripción completa

Detalles Bibliográficos
Autores principales: Haghighi, Sara, Forsmark, Sara, Zachrisson, Olof, Carlsson, Arvid, Nilsson, Marie K. L., Carlsson, Maria L., Schuit, Robert C., Gottfries, Carl‐Gerhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035472/
https://www.ncbi.nlm.nih.gov/pubmed/33528911
http://dx.doi.org/10.1002/brb3.2040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035472/
https://www.ncbi.nlm.nih.gov/pubmed/33528911
http://dx.doi.org/10.1002/brb3.2040

Ejemplares similares